Avo In R/R And Previously Untreated MCL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Avo In R/R And Previously Untreated MCL — Stella

Home/Mantle Cell Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to Mantle Cell Lymphoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

University of Chicago Medical Center, Chicago, Illinois

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Key details

Phase

Early testing / Safety & dosing

Sponsor

Austin I Kim

Collaborators

Roche-Genentech, AstraZeneca

Enrollment target

~72 participants

Started

July 2021

Primary completion

June 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.